John Stone
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Oncology top 5%
- PARP inhibition in cancer therapy
Papers in
- Oncology 4
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 1
-
- Cancer-related gene regulation 1
- Protein Degradation and Inhibitors 1
- RNA Interference and Gene Delivery 1
- Co-authors
- Christina Messiou (1 shared paper)Susan Shanley (1 shared paper)Alan Ashworth (1 shared paper)Peter C.C. Fong (1 shared paper)David S. Boss (1 shared paper)Timothy A. Yap (1 shared paper)Stan B. Kaye (1 shared paper)Roger A’Hern (1 shared paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
John Stone
5 papers receiving 779 citations
John Stone's Hit Papers
Peers
Comparison fields: 5 of 47
- Reproductive Medicine 194
- Oncology 580
- Cancer Research 90
- Genetics 177
- Molecular Biology 361
Countries citing papers authored by John Stone
This map shows the geographic impact of John Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Stone more than expected).
Fields of papers citing papers by John Stone
This network shows the impact of papers produced by John Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Stone. The network helps show where John Stone may publish in the future.
Co-authors
The 25 scholars most cited alongside John Stone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval Hit paper breakdown → | 2010 | 753 |
| 2 | 2024 | 30 | |
| 3 | 2021 | 5 | |
| 4 | 2024 | 3 | |
| 5 | 2022 | 1 |
About John Stone
John Stone is a scholar working on Oncology, Molecular Biology, Immunology, Hematology and Infectious Diseases, having authored 5 papers that have together received 792 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Cancer-related gene regulation (1 paper), Protein Degradation and Inhibitors (1 paper), Biosimilars and Bioanalytical Methods (1 paper), Immune Cell Function and Interaction (1 paper) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Reproductive Medicine (194 citations), Oncology (580 citations), Cancer Research (90 citations), Genetics (177 citations) and Molecular Biology (361 citations). John Stone has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Christina Messiou, Susan Shanley, Alan Ashworth, Peter C.C. Fong, David S. Boss, Timothy A. Yap, Stan B. Kaye, Roger A’Hern, Jan Lubiński and Jan H.M. Schellens. Their work appears in journals such as Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.